Latest News

Non-lethal weapons company Byrna (NASDAQ:BYRN) met Wall Street’s revenue expectations in Q2 CY2025, with sales up 40.6% year on year to $28.51 million. Its GAAP profit of $0.10 per share was 42.9% above analysts’ consensus estimates.

Which of these speculative AI plays has a brighter future?

Wondering if now is the time to buy Costco? Spoiler alert -- it's very rarely a bad idea to hold this stock for a few years.

Packaged foods company Conagra Brands (NYSE:CAG) missed Wall Street’s revenue expectations in Q2 CY2025, with sales falling 4.3% year on year to $2.78 billion. Its non-GAAP profit of $0.56 per share was 8.2% below analysts’ consensus estimates.

These three chip equipment makers are essential to AI infrastructure, making them key long-term beneficiaries of data center growth

The GBP/USD pair dropped to 1.3602 on Thursday, marking a two-week low amid a strengthening US dollar and growing concerns over the UK’s public finances.

Oracle has been among the top-performing U.S. stocks in the last year, and signs point to continued growth as the company asserts AI and cloud dominance.

QUALCOMM INC (NASDAQ:QCOM) is a strong dividend stock with a 2.19% yield, solid profitability, and a healthy balance sheet, making it a reliable pick for income investors.

I missed out on over $10K in interest before I learned about high-yield savings accounts -- here's how to avoid that same mistake.

Before the US market kicks off on Thursday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.

Crypto market is extending higher as anticipated, and while Bitcoin is losing dominance, we might be in the ALTseason by Elliott wave theory.

RAMBUS INC (NASDAQ:RMBS) meets Minervini’s Trend Template with strong technicals and high growth fundamentals, making it a candidate for momentum investors.

The EUR/USD exchange rate pulled back slightly, continuing a trend that started earlier this month when it peaked at 1.1826.

Nuclear energy might be the next big momentum play in the global stock market, with three names that stand out to deliver upside.

CEO Michael Lohscheller noted that the company “delivered another strong quarter of growth” in spite of increasingly challenging market and geopolitical conditions.

Meta just invested more than $14 billion into data labeling start-up Scale AI, acquiring a 49% equity stake in the process.

Pelthos launches Zelsuvmi, the first FDA-approved at-home prescription gel for molluscum, shown to clear lesions in as little as two weeks.

With the amount of Treasury debt now in sharp focus, it’s worth cutting through the technical jargon used by the media to quantify demand at Treasury auctions.